Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (121-130 of 243) with videos related to

Pageof 25
Sort By:
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Radiation Oncology (London, England)|January 5, 2017
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.govNikola Cihoric, Alexandros Tsikkinis, Giuseppe Minniti, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Frontiers in Oncology|November 17, 2022
Postoperative prolonged mechanical ventilation correlates to poor survival in patients with surgically treated spinal metastasisMotaz Hamed, Simon Brandecker, Shaleen Rana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Epilepsia|October 29, 2024
Proof of concept: Portable ultra-low-field magnetic resonance imaging for the diagnosis of epileptogenic brain pathologiesTobias Bauer, Simon Olbrich, Anne Groteklaes, et al.
Cancer Research|November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivoMartin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.
Pageof 25

Showing results (121-130 of 243) with videos related to

Sort By:
Pageof 25
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Radiation Oncology (London, England)|January 5, 2017
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.govNikola Cihoric, Alexandros Tsikkinis, Giuseppe Minniti, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Frontiers in Oncology|November 17, 2022
Postoperative prolonged mechanical ventilation correlates to poor survival in patients with surgically treated spinal metastasisMotaz Hamed, Simon Brandecker, Shaleen Rana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Epilepsia|October 29, 2024
Proof of concept: Portable ultra-low-field magnetic resonance imaging for the diagnosis of epileptogenic brain pathologiesTobias Bauer, Simon Olbrich, Anne Groteklaes, et al.
Cancer Research|November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivoMartin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.
Pageof 25